<div class="welcome-screen" id="welcomeScreen">
  <div class="welcome-banner">
    <h1 id="welcome-title">Welcome to Chapter II of Brain Injury Medicine!</h1>
    <p id="welcome-description">Explore the following topics to enhance your
      knowledge.</p>
  </div>
<div class="explanation-card">
  <h1>Chapter 6: The Epidemiology of Traumatic Brain Injury (TBI)</h1>
  <h2>Public Health Perspective</h2>
  <p> The<b>epidemiology of TBI</b> is central to understanding its<b>public health burden</b>, which includes death,
    disability, and long-term care needs. According to the<b>CDC definition (1995)</b>, TBI encompasses injuries to the
    head from<b>blunt, penetrating, or acceleration/deceleration forces</b>, with associated features like<b>altered
    consciousness, amnesia, neurological signs, or intracranial lesions</b>. This definition prioritizes inclusivity for
   <b>surveillance</b>, capturing even<b>mild injuries</b> without obvious deficits. </p>
  <h3>Severity and Outcomes</h3>
  <p> TBI severity refers to<b>acute disruption</b> in brain physiology or structure and is typically assessed using the
   <b>Glasgow Coma Scale (GCS)</b>. However, the designation of "mild" can be misleading, as some patients develop
   <b>long-lasting impairment</b>. Outcomes depend on<b>survival</b>,<b>disability</b>, and<b>recovery trajectories</b>—factors
    that help shape rehabilitation strategies. </p>
  <h3>Incidence, Trends, and Demographics</h3>
  <p> In the U.S., TBI leads to over<b>50,000 deaths yearly</b>, a third of all injury-related deaths. Hospitalizations
    for nonfatal TBI reach<b>230,000 annually</b>, with<b>80,000</b> progressing to long-term disability. Trends show a
   <b>decline in TBI deaths</b> from motor vehicle accidents but an<b>increase in firearm-related deaths</b>. Incidence
    peaks among<b>young adults (15–24)</b> and the<b>elderly (75+)</b>, with<b>males</b> being disproportionately affected.
    Major causes include<b>transport accidents (49%)</b>,<b>falls (26%)</b>, and<b>firearms (10%)</b>. </p>
  <div class="mnemonic">
    <p><strong>Mnemonic: "MAFIA" — Motor Accidents, Falls, Intentional Acts (firearms/violence), Age extremes — the core
        demographics and causes in TBI epidemiology.</strong></p>
  </div>
  <h3>Economic Burden</h3>
  <p> In 1985, the<b>total lifetime cost</b> of TBI was estimated at<b>$37.8 billion</b>, rising to<b>$56.3 billion by
    1995</b>. The main drivers are<b>work loss</b>,<b>disability</b>, and<b>premature death</b>, making prevention and early
    intervention economically vital. </p>
</div>
<div class="question-card">
  <h1>Question 1</h1>
  <p>Which age group has the highest rate of fall-related TBI?</p>
  <ul class="options" id="options">
    <li data-answer="wrong">15–24 years</li>
    <li data-answer="correct">75 years and older</li>
    <li data-answer="wrong">5–14 years</li>
  </ul>
</div>
<div class="explanation-card">
  <h1>Chapter 7: Primary Prevention of TBI</h1>
  <h2>Framework and Prevention Strategy</h2>
  <p> Preventing TBI requires a<b>multifaceted approach</b> targeting injury occurrence, severity, and consequences. The
   <b>Haddon Matrix</b> frames prevention into<b>host</b>,<b>agent</b>, and<b>environment</b> across the<b>pre-injury, injury,
    and post-injury phases</b>. Strategies are either<b>active</b> (requiring user participation like seatbelt use) or
   <b>passive</b> (automatic, like airbags). </p>
  <h3>Vehicle Safety and Helmets</h3>
  <p> Motor vehicles are the<b>leading cause</b> of TBI. Combined<b>seatbelt and airbag use</b> reduces moderate-to-severe
    head injuries by up to<b>83%</b>.<b>Helmet use</b> among motorcyclists is critically protective, and<b>mandatory laws</b>
    significantly lower fatalities and costs. The repeal of helmet laws correlates with increased injuries. </p>
  <h3>Falls and Sports</h3>
  <p> Fall-related TBIs, especially in children and the elderly, are preventable through measures like<b>window
    guards</b>,<b>playground safety</b>, and<b>home modifications</b>. In sports,<b>helmets</b>,<b>rule enforcement</b>, and
   <b>behavioral training</b> reduce concussion risk. For example,<b>bicycle helmets lower brain injury risk by 88%</b>.
  </p>
  <h3>Violence, Suicide, and Substance Use</h3>
  <p> Firearms are a major cause of fatal TBI, often related to<b>suicide</b>, which is<b>2.7–4x more likely</b> in TBI
    populations. Gun control laws,<b>trigger locks</b>, and<b>mental health interventions</b> are critical.<b>Alcohol</b> is a
    potent risk factor, addressed by<b>server intervention</b>,<b>BAC limits</b>, and<b>sobriety checkpoints</b>. </p>
  <div class="mnemonic">
    <p><strong>Mnemonic: "SAFE HEAD" — Seatbelts, Alcohol laws, Falls prevention, Education, Helmets, Enforcement,
        Age-targeted interventions, Design modifications — key pillars of primary prevention.</strong></p>
  </div>
</div>
<div class="question-card">
  <h1>Question 2</h1>
  <p>What is the most effective combined protection against head injury in motor vehicle crashes?</p>
  <ul class="options" id="options">
    <li data-answer="wrong">Seatbelt alone</li>
    <li data-answer="wrong">Airbag alone</li>
    <li data-answer="correct">Seatbelt and airbag together</li>
  </ul>
</div>
<div class="explanation-card">
  <h1>Chapter 8: TBI Pathobiology</h1>
  <h2>Primary vs. Secondary Injury</h2>
  <p><b>Primary injury</b> includes the<b>initial mechanical disruption</b>—cortical and axonal shearing, vascular rupture,
    and mass glutamate release.<b>Secondary injury</b> evolves over time, involving<b>ischemia</b>,<b>excitotoxicity</b>,
   <b>apoptosis</b>,<b>edema</b>, and<b>inflammation</b>, all of which can worsen outcomes and are potential targets for
    therapy. </p>
  <h3>Excitotoxicity and Apoptosis</h3>
  <p><b>Glutamate-mediated excitotoxicity</b> drives<b>calcium influx</b>, triggering mitochondrial dysfunction and
    activating<b>caspases</b>.<b>Apoptotic pathways</b>—both intrinsic and extrinsic—lead to neuronal death. Molecules like
   <b>Bcl-2</b> counteract these processes and correlate with better recovery. </p>
  <h3>Traumatic Axonal Injury and Edema</h3>
  <p><b>Traumatic axonal injury (TAI)</b> results from delayed<b>calcium-mediated cytoskeletal failure</b>. Meanwhile,
   <b>brain swelling</b> stems mainly from<b>vasogenic and cytotoxic edema</b>, not increased blood volume. Controlling
   <b>intracranial pressure (ICP)</b> is crucial in critical care. </p>
  <h3>Inflammation and Recovery</h3>
  <p> TBI induces<b>IL-1β, IL-6, and neutrophilic infiltration</b>. Some cytokines, like IL-6, promote<b>nerve growth
    factor (NGF)</b> expression and may aid<b>plasticity</b>. The inflammatory process is<b>double-edged</b>: essential for
    repair, yet damaging in excess. </p>
</div>
<div class="question-card">
  <h1>Question 3</h1>
  <p>What neurotransmitter plays a major role in post-TBI excitotoxicity?</p>
  <ul class="options" id="options">
    <li data-answer="correct">Glutamate</li>
    <li data-answer="wrong">Dopamine</li>
    <li data-answer="wrong">Serotonin</li>
  </ul>
</div>
<div class="explanation-card">
  <h1>Chapter 9: CNS Plasticity and Recovery</h1>
  <h2>From Dogma to Dynamic Reorganization</h2>
  <p> Traditional neuroscience viewed the<b>adult brain as static</b>. However, studies from<b>Raisman, Lashley, and
    Luria</b> reveal that<b>functional recovery</b> can result from<b>true reorganization</b>, not just compensation. This
    reorganization may occur via<b>unmasking of silent pathways</b>,<b>cortical remapping</b>, or<b>diaschisis resolution</b>.
  </p>
  <h3>Concepts of Plasticity</h3>
  <p><b>Equipotentiality and vicariation</b> suggest that<b>other brain regions</b> can assume functions of damaged areas.
    The<b>serial lesion effect</b> and recovery after<b>slow-growing tumors</b> further support dynamic substitution. Even
   <b>phantom limb phenomena</b> reflect reorganization. </p>
  <h3>Diaschisis and Unmasking</h3>
  <p><b>Diaschisis</b> describes remote suppression of neural activity post-injury. Recovery involves<b>reactivation</b> of
    these dormant circuits. Studies show<b>adjacent cortical areas</b> expand their receptive fields after damage, a basis
    for<b>rehabilitation strategies</b> like constraint-induced movement therapy. </p>
  <div class="mnemonic">
    <p><strong>Mnemonic: "RED PLASTIC" — Reorganization, Equipotentiality, Diaschisis, Plasticity, Lesion effect,
        Activity-dependence, Silent pathway unmasking, Training, Integration, Compensation — principles of CNS
        recovery.</strong></p>
  </div>
</div>
<div class="question-card">
  <h1>Question 4</h1>
  <p>What concept explains recovery from suppressed but intact neural circuits?</p>
  <ul class="options" id="options">
    <li data-answer="wrong">Hyperplasticity</li>
    <li data-answer="correct">Diaschisis</li>
    <li data-answer="wrong">Neurogenesis</li>
  </ul>
</div>
<div class="explanation-card">
  <h1>Chapter 10: Innovative Therapies for Neural Recovery</h1>
  <h2>Experimental Approaches</h2>
  <p> Numerous<b>experimental therapies</b> target secondary injury mechanisms. These include<b>glutamate inhibitors</b>,
   <b>NMDA antagonists</b>,<b>calcium channel blockers</b>, and<b>antioxidants</b> like Vitamin E or melatonin. Each aims to
    prevent or limit cellular damage. </p>
  <h3>Growth Factors and Hormones</h3>
  <p><b>NGF, FGF-2, and IGF-1</b> show promise in promoting<b>neurogenesis</b>,<b>memory recovery</b>, and<b>cell survival</b>.
   <b>Progesterone</b> reduces edema and improves outcomes, while<b>estrogen</b> may protect cerebral blood flow. These
    findings reflect the influence of<b>gender on recovery</b>. </p>
  <h3>Mitochondrial, Neurotransmitter, and Behavioral Strategies</h3>
  <p> Drugs like<b>cyclosporin A</b> target mitochondrial stability.<b>Catecholamine agonists</b>,<b>serotonin receptor
    modulators</b>, and<b>cholinergic agents</b> (e.g., donepezil) enhance<b>functional performance</b> and<b>plasticity</b>.
   <b>Environmental enrichment</b> improves outcomes via sensory stimulation and cortical growth.<b>Stem cell
    transplantation</b> and<b>nutraceuticals</b> like magnesium are also under active investigation. </p>
  <p> While many therapies succeed in animal models,<b>clinical translation remains limited</b>, underscoring the need for
    human-relevant trials. </p>
</div>
<div class="question-card">
  <h1>Question 5</h1>
  <p>Which agent stabilizes mitochondria and reduces axonal damage after TBI?</p>
  <ul class="options" id="options">
    <li data-answer="wrong">Vitamin B3</li>
    <li data-answer="wrong">Galanin</li>
    <li data-answer="correct">Cyclosporin A</li>
  </ul>
</div>

  <div class="placeholder" id="empty">Test</div>

</div>